You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 5, February 7, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Opportunities for Medical Research
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Ethics
 •Statistics and Research Methods
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic

Gene and Stem Cell Therapies

Eugene H. Kaji, MD; Jeffrey M. Leiden, MD, PhD

JAMA. 2001;285:545-550.

Gene and stem cell therapies hold promise for the treatment of a wide variety of inherited and acquired human diseases. Identification of genes involved in human disease and development of novel vectors and devices for delivering therapeutic genes to different tissues in vivo have resulted in significant progress in the area of gene therapy. Isolation of stem cells from organs formerly thought to have no regenerative potential, the demonstration of stem cell plasticity, and the creation of human embryonic stem cells clearly demonstrate the feasibility of human stem cell therapy. Much additional work remains to be done in the areas of vector development and stem cell biology before the full therapeutic potential of these approaches can be realized. Of equal importance, the ethical issues surrounding gene- and cell-based therapies must be confronted.


Author Affiliations: Harvard School of Public Health (Drs Kaji and Leiden) and Brigham and Women's Hospital (Dr Kaji), Boston, Mass; Veterans Affairs Boston Healthcare System, Jamaica Plain, Mass (Dr Kaji); and Abbott Laboratories, Abbott Park, Ill (Dr Leiden).


RELATED ARTICLE

February 7, 2001
JAMA. 2001;285(5):665-666.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Approaches to Utilize Mesenchymal Progenitor Cells as Cellular Vehicles
Pereboeva et al.
Stem Cells 2003;21:389-404.
ABSTRACT | FULL TEXT  

Intratracheal adenovirus-mediated gene transfer is optimal in experimental lung transplantation
Kanaan et al.
J. Thorac. Cardiovasc. Surg. 2002;124:1130-1136.
ABSTRACT | FULL TEXT  

The Orthopaedic Genome: What Does the Future Hold and Are We Ready?
Puzas et al.
JBJS 2002;84:133-141.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.